These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 33917954)

  • 1. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
    Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma cancer stem cell biology: Potential theranostic targets.
    Sharifzad F; Ghavami S; Verdi J; Mardpour S; Mollapour Sisakht M; Azizi Z; Taghikhani A; Łos MJ; Fakharian E; Ebrahimi M; Hamidieh AA
    Drug Resist Updat; 2019 Jan; 42():35-45. PubMed ID: 30877905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
    Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies targeting glioblastoma stem cells.
    Carrasco-Garcia E; Sampron N; Aldaz P; Arrizabalaga O; Villanua J; Barrena C; Ruiz I; Arrazola M; Lawrie C; Matheu A
    Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):216-27. PubMed ID: 23607282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self‑renewal signaling pathways and differentiation therapies of glioblastoma stem cells (Review).
    Jin J; Grigore F; Chen CC; Li M
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies.
    Ryskalin L; Gaglione A; Limanaqi F; Biagioni F; Familiari P; Frati A; Esposito V; Fornai F
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting role of glioma stem cells for glioblastoma multiforme.
    Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ
    Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells.
    Torres Á; Arriagada V; Erices JI; Toro MLÁ; Rocha JD; Niechi I; Carrasco C; Oyarzún C; Quezada C
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
    Shin HJ; Lee S; Jung HJ
    J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells.
    Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.
    Biserova K; Jakovlevs A; Uljanovs R; Strumfa I
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatment strategies to eradicate cancer stem cells and niches in glioblastoma.
    Hide T; Makino K; Nakamura H; Yano S; Anai S; Takezaki T; Kuroda J; Shinojima N; Ueda Y; Kuratsu J
    Neurol Med Chir (Tokyo); 2013; 53(11):764-72. PubMed ID: 24140771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated invasive potential of glioblastoma stem cells.
    Cheng L; Wu Q; Guryanova OA; Huang Z; Huang Q; Rich JN; Bao S
    Biochem Biophys Res Commun; 2011 Mar; 406(4):643-8. PubMed ID: 21371437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.
    Huang Z; Cheng L; Guryanova OA; Wu Q; Bao S
    Protein Cell; 2010 Jul; 1(7):638-55. PubMed ID: 21203936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.
    Guerriero C; Matera C; Del Bufalo D; De Amici M; Conti L; Dallanoce C; Tata AM
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating voltage-gated sodium channels to enhance differentiation and sensitize glioblastoma cells to chemotherapy.
    Giammello F; Biella C; Priori EC; Filippo MADS; Leone R; D'Ambrosio F; Paterno' M; Cassioli G; Minetti A; Macchi F; Spalletti C; Morella I; Ruberti C; Tremonti B; Barbieri F; Lombardi G; Brambilla R; Florio T; Galli R; Rossi P; Brandalise F
    Cell Commun Signal; 2024 Sep; 22(1):434. PubMed ID: 39251990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.